ATB0,+-targeted nanoparticles initiate autophagy suppression to overcome chemoresistance for enhanced colorectal cancer therapy.
Chen Z, Chen H, Huang L, Duan B, Dai S, Cai W, Sun M, Jiang Z, Lu R, Jiang Y, Jiang X, Zheng H, Yao Q, Kim K, Lin G, Xie C, Chu M, Chen R, Kou L.
Chen Z, et al. Among authors: chu m.
Int J Pharm. 2023 Jun 25;641:123082. doi: 10.1016/j.ijpharm.2023.123082. Epub 2023 May 25.
Int J Pharm. 2023.
PMID: 37244464